Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Smith & Nephew announced the launch of the TRUCLEAR System

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Sutter Health and Allina Health Sign...

Sutter Health and Allina Health, both nonprofit health systems,...

GHO Capital and CBC Group to...

Two of the world's prominent healthcare-focused investment firms London-based...

Artivion Acquires Endospan for $135M Following...

US-based medical device company Artivion has completed its acquisition...

Smith & Nephew’s Endoscopy Division announced the launch of the TRUCLEAR? System, an operative hysteroscopy device, which is now widely available in the United States. In conjunction with the announcement, Smith & Nephew will host a panel discussion about hysteroscopy at this year’s American Association of Gynecologic Laparoscopists (AAGL) annual meeting, which is being held in Orlando, Fla.

The TRUCLEAR System is a first-of-its kind device that enables a fast and thorough capture and removal of intrauterine polyps and fibroids, and provides healthcare practitioners in obstetrics and gynecology and reproductive health with a uniquely user-friendly technique. The system pairs the visualization capabilities of a hysteroscope with the tissue removal capabilities of a morcellator, allowing healthcare practitioners a quick capture and removal of polyps and fibroids.

Mira Sahney, Director of Gynecology at Smith & Nephew Endoscopy said, The availability of the TRUCLEAR System provides healthcare practitioners a safe and much-needed option for the half a million women in the United States who seek treatment for intrauterine polyps and fibroids. Current treatments pose significant challenges, ranging from using electricity in the uterus to obstructed visibility. With the TRUCLEAR System, clarity is uncompromised and the uterus remains intact, so that practitioners can focus on efficiently and safely treating their patients.

Never miss a healthcare headline

Healthcare moves fast – stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Sutter Health and Allina Health Sign Definitive Agreement to Join Forces

Sutter Health and Allina Health, both nonprofit health systems,...

GHO Capital and CBC Group to Build the Largest Pan-Asian Healthcare Investment Platform

Two of the world's prominent healthcare-focused investment firms London-based...

Artivion Acquires Endospan for $135M Following FDA Approval of NEXUS Aortic Graft Stent System

US-based medical device company Artivion has completed its acquisition...

NHS Plans Single Patient Record to Transform Healthcare

The National Health Service is moving forward with plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »